Recommended Pages at topics.wsj.com
Sign of Good Hand Hygiene - WSJ.com
topics.wsj.com — “Sign of Good Hand Hygiene - WSJ.com” View full resource at topics.wsj.com
Most Recently Shared on September 6, 2011 at 11:02 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/6mnKW A new way to get docs to wash their hands in the hospital
Scott Simon: The Case for Adoption - WSJ.com
topics.wsj.com — “In The Wall Street Journal, NPR's Scott Simon writes that the story of the baby boy who was floated into the bulrushes along the Nile reminds us that the instinct to care for castaway children is ancient and inborn.” View full resource at topics.wsj.com
Most Recently Shared on December 17, 2010 at 12:40 pm By:
Nick Dawson Health Social Media and Health IT
RT @nprscottsimon: Link to article I have in today's WSJ on miracle of adoption: http://tinyurl.com/29cne3s Tis the season. Always-
Amgen's Profit Falls 11% - WSJ.com
topics.wsj.com — “Amgen reported an 11% drop in profit as the drug company's operating costs rose and revenue was essentially flat.” View full resource at topics.wsj.com
Most Recently Shared on October 26, 2010 at 11:08 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/2Zsim Amgen net income drops 11% as osteoporosis drug disappoints
FDA to Rescind Approval of Knee Device - WSJ.com
topics.wsj.com — “The FDA said it planned to revoke a medical-device company's right to sell a knee implant called Menaflex after an unprecedented yearlong review concluded the agency erred in allowing it on the market.” View full resource at topics.wsj.com
Most Recently Shared on October 15, 2010 at 2:33 pm By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/2U3T0 FDA to revoke approval for Menaflex a knee device
Novartis in Pact to Speed Up Vaccine Production - WSJ.com
topics.wsj.com — “Novartis said it entered a partnership with newly formed Synthetic Genomic Vaccines to use new technologies aimed at speeding up production of seasonal and pandemic flu vaccines.” View full resource at topics.wsj.com
Most Recently Shared on October 8, 2010 at 10:35 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/2QvJS Novartis partners with Synthetic Genomics Vaccines (Craig Venter)
Drugs Show Promise to Prevent Clots - WSJ.com
topics.wsj.com — “Studies of two experimental drugs provided fuel for a race to develop medicines to replace blood thinner warfarin for the prevention of blood clots, a global market that could eventually exceed $20 billion a year in revenue.” View full resource at topics.wsj.com
Most Recently Shared on September 1, 2010 at 4:04 pm By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/2xZvc Dabigatran, Revaroxaban, Apixaban, Edoxaban, Betrixaban all go after $20 billion a year bood thinner market
